LSP

BIOLOGICAL2 trials

Sponsors

U.S. Army Medical Research and Development Command, Zagazig University

Conditions

Hip FracturesThrombocytopenia

Phase 1

Phase 1 Safety Study of Dimethyl Sulfoxide Cryopreserved Platelets

CompletedNCT02078284

U.S. Army Medical Research and Development CommandThrombocytopenia

Start: 2014-11-05End: 2016-07-17Updated: 2021-05-20

Unknown Phase

Circum-Psoas Blocks Versus Combined Lumbar and Sacral Plexus Blocks in Hip Fracture Surgery

RecruitingNCT05660603

Zagazig UniversityHip Fractures

Start: 2022-12-20End: 2026-04-01Target: 63Updated: 2025-07-17

Related Papers

Treatment of Bleeding in Severely Thrombocytopenic Patients with Transfusion of Dimethyl Sulfoxide (DMSO) Cryopreserved Platelets (CPP) Is Safe - Report of a Phase 1 Dose Escalation Safety Trial

Blood2016-12-026 citations